Ipilimumab/NivolumabHepatotoxicity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72277-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：168 / 168

相关论文

共 50 条

[41] Ipilimumab/nivolumabPapilloedema: case report
Reactions Weekly, 2019, 1768 (1) : 198 - 198
[42] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1926 (1) : 277 - 277
[43] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2018, 1722 (1) : 192 - 192
[44] Ipilimumab/NivolumabMyelosuppression : case report
Reactions Weekly, 2024, 2017 (1) : 252 - 252
[45] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1931 (1) : 319 - 319
[46] Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly, 2021, 1884 (1) : 239 - 239
[47] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1901 (1) : 281 - 281
[48] Ipilimumab/nivolumabDermatomyositis: case report
Reactions Weekly, 2020, 1819 (1) : 157 - 157
[49] Ipilimumab/nivolumabOesophagitis: case report
Reactions Weekly, 2021, 1869 (1) : 195 - 195
[50] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2019, 1770 (1) : 225 - 225

← 1 2 3 4 5 →